
The chairman of the Wasdell Group, whose application to build
a science park in Swindon was turned down by Swindon Borough Council’s planning
committee in August 2020, has announced the company is to appeal the decision.
Since buying Wasdell in 2009, Martin Tedham has transformed
what was an unprofitable local pharmaceutical packaging company turning over
£2m a year into one of Europe’s largest independent partners to the
pharmaceutical industry, turning over £52m and employing 750 people in Swindon.
During Covid-19 pandemic Wasdell has worked with providers of
medical-grade antiseptic products to deliver to patients and the general
public, and is also managing the delivery of investigational medicinal products
to patients taking part in clinical trials.